HomeCompareOCEAW vs EPRT

OCEAW vs EPRT: Dividend Comparison 2026

OCEAW yields 6711.41% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCEAW wins by $1097629163471472.38M in total portfolio value
10 years
OCEAW
OCEAW
● Live price
6711.41%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1097629163471472.38M
Annual income
$1,066,373,173,675,476,400,000.00
Full OCEAW calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — OCEAW vs EPRT

📍 OCEAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCEAWEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCEAW + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCEAW pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCEAW
Annual income on $10K today (after 15% tax)
$570,469.80/yr
After 10yr DRIP, annual income (after tax)
$906,417,197,624,154,900,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, OCEAW beats the other by $906,417,197,624,154,900,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCEAW + EPRT for your $10,000?

OCEAW: 50%EPRT: 50%
100% EPRT50/50100% OCEAW
Portfolio after 10yr
$548814581735736.19M
Annual income
$533,186,586,837,738,200,000.00/yr
Blended yield
97.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

OCEAW
No analyst data
Altman Z
-268.6
Piotroski
1/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCEAW buys
0
EPRT buys
0
No recent congressional trades found for OCEAW or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCEAWEPRT
Forward yield6711.41%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$1097629163471472.38M$63.4K
Annual income after 10y$1,066,373,173,675,476,400,000.00$12,840.73
Total dividends collected$1095532211199846.75M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: OCEAW vs EPRT ($10,000, DRIP)

YearOCEAW PortfolioOCEAW Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$681,841$671,140.94$11,205$505.18+$670.6KOCEAW
2$43,496,987$42,767,417.65$12,672$682.46+$43.48MOCEAW
3$2,596,337,307$2,549,795,530.67$14,490$930.48+$2596.32MOCEAW
4$145,018,660,220$142,240,579,301.68$16,786$1,282.69+$145018.64MOCEAW
5$7,580,273,425,477$7,425,103,459,041.20$19,753$1,791.56+$7580273.41MOCEAW
6$370,837,750,892,272$362,726,858,327,011.50$23,677$2,541.64+$370837750.87MOCEAW
7$16,981,014,621,956,098$16,584,218,228,501,366.00$29,008$3,672.99+$16981014621.93MOCEAW
8$727,896,026,099,293,400$709,726,340,453,800,300.00$36,463$5,425.08+$727896026099.26MOCEAW
9$29,211,205,416,818,827,000$28,432,356,668,892,580,000.00$47,238$8,221.57+$29211205416818.78MOCEAW
10$1,097,629,163,471,472,400,000$1,066,373,173,675,476,400,000.00$63,385$12,840.73+$1097629163471472.38MOCEAW

OCEAW vs EPRT: Complete Analysis 2026

OCEAWStock

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.

Full OCEAW Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this OCEAW vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCEAW vs SCHDOCEAW vs JEPIOCEAW vs OOCEAW vs KOOCEAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.